Fig 1. (A) A simple route to prepare AC-Cur. (B) HepG2 cell viability after treatment of free Cur or AC-Cur for 1 day, 2 days and 3 days (n = 4). Cell viability of control (untreated HepG2 cells): 100%.
Wang, S.; Cao, H.; Shao, Z., Hydrophilic aminoclay-curcumin nanohybrids for enhanced chemotherapy. Nanomedicine-Nanotechnology Biology and Medicine 2016, 12, (2), 512.
Copyright © 上海复旦大学
